Drainage Design Specialist leading drainage design projects from concept to completion. Working across the UK to deliver innovative and reliable drainage solutions for various clients.
About the role
- Director of Clinical Biomarkers leading biomarker strategy for late-stage oncology clinical development at GSK. Collaborating with internal teams to align biomarker validation with clinical plans.
Responsibilities
- Responsible for the development and effective implementation of biomarker and translational medicine strategies to support the clinical development of late-stage oncology assets.
- Collaborate with the Clinical Biomarker Executive Director, to establish clear decision-making criteria, define patient segmentation strategies, and integrate these into clinical development plans.
- Leverage cutting-edge technologies and methodologies to discover and clinically validate biomarkers, ensuring the biomarker strategy is fully aligned with the clinical plan.
- Optimize decision-making in drug development and enable the identification of the right patient populations for medicines.
- Collaborate closely with the Clinical Biomarker Executive Director to drive the design, alignment, and execution of clinical biomarker and translational medicine strategies focused on identifying predictive biomarkers that enable clinical success.
- Validate and implement biomarker strategies, including target engagement, pharmacodynamic, and proof-of-mechanism biomarkers, for clinical-phase programs to support patient stratification, dose selection, and enable clinical go/no-go decisions.
- Participate in tumor-specific Biomarker Matrix teams, with responsibility for executing clinical biomarker strategies for late-stage oncology programs, while working closely with internal and external stakeholders, as well as disease area strategy teams.
- Represent Translational Medicine at Clinical Development Matrix Teams (CMT) to establish biomarker-driven decision-making criteria and their seamless integration into clinical study designs, aligning with clinical study objectives.
- Identify cutting-edge science and technological advances to incorporate into biomarker strategies for guiding indication selection, patient enrichment, and combination strategies.
- Oversee and/or develop sample testing plans and delivering high-quality biomarker data packages to inform clinical development and regulatory strategies.
- Manage effective relationships with clinical and scientific operations, diagnostics, medical science, medical affairs, regulatory, portfolio management, and commercial functions.
- Support the expansion of mechanism and disease understanding to generate insights for indication expansion and scientific exchange as needed.
- Contribute to the company’s scientific credibility through publications and presentations.
Requirements
- Minimum of 5 years of experience in the pharmaceutical industry, with a solid background in oncology clinical biomarkers -expertise in late-phase oncology studies- and translational research within clinical development.
- Background as a Scientist and/or Physician.
- Proven ability to lead cross-functional teams and execute strategic biomarker plans.
- Experience conducting clinical trials and working as part of clinical study teams.
- Expertise in interpreting clinical biomarker data and evaluating innovative biomarker technologies for clinical trial applications.
- Strong interpersonal skills and ability to thrive in a team-oriented environment.
- Demonstrated ability to influence teams and key leaders, with a track record of success.
Benefits
- Comprehensive benefits program GSK offers US employees
Job title
Job type
Experience level
Salary
Not specified
Degree requirement
Location requirements
European Supply Planning Director at Solenis overseeing supply and inventory planning across Europe. Driving strategic and operational excellence in a senior leadership role.
Executive Director leading analytics and primary market research for oncology business unit at Amgen, driving commercial performance and decision - making.
Executive Director leading integrated analytics and market research for the Inflammation & Bone Business Unit at Amgen. Transforming patient lives through innovative medicines in biotech.
Executive Director responsible for analytics and market research for Cardiovascular Business Unit. Leading integrated analytics organization and driving commercial performance with data - driven insights.
Associate Director leading lead monetization strategies for optimizing revenue. Overseeing team performance and strategy execution in Wisconsin and Tennessee locations.
Regional Director responsible for executing agency distribution strategies at Travelers. Collaborating with teams to enhance product line growth and identifying new production sources.
Director of Product Development at Travelers leading product strategies and enhancements in the insurance sector. Focused on driving financial objectives through product management and team leadership.
Managing Director leading a team of underwriters providing surety bonds for construction projects. Evaluating financial risk and collaborating with agents and brokers to achieve business goals.
Senior Director leading U.S. advocacy strategy across Gilead’s Oncology portfolio, focusing on a late - stage asset. Collaborating with Commercial, Medical Affairs, and Government Affairs teams to address unmet needs.